Efficacy and safety of low‐dose oral lenalidomide in refractory cutaneous lupus erythematosus: an open series of 19 cases

$Efficacy and safety of low‐dose oral lenalidomide in refractory cutaneous lupus erythematosus: an open series of 19 cases$

Article de revue

Avec comité de lecture

V. Reymann, D. Bessis, B. Bergeret, D. Lipsker, A. Du-Thanh, N. Terrail, M. Dandurand et O. Dereure

Journal of the European Academy of Dermatology and Venereology, Vol.35(2), pp.e113-e115

02/2021

PMID: 32730681

Résumé

Humans

Lenalidomide

Lupus Erythematosus, Cutaneous

Thalidomide

Treatment Outcome

url

Find in HALAfficher

1 Consultations de la notice

Titre: Efficacy and safety of low‐dose oral lenalidomide in refractory cutaneous lupus erythematosus: an open series of 19 cases
Créateurs - sans rôle: V. Reymann - Inserm
D. Bessis - Inserm
B. Bergeret - Université de Nîmes
D. Lipsker - Université de Strasbourg
A. Du-Thanh - Pathogenesis and Control of Chronic and Emerging Infections
N. Terrail - Centre Hospitalier Universitaire de Montpellier
M. Dandurand - Université de Nîmes
O. Dereure - Inserm
Détails de publication: Journal of the European Academy of Dermatology and Venereology, Vol.35(2), pp.e113-e115
Identifiants: 99151005509311
Unité académique: Pathogenesis and Control of Chronic and Emerging Infections - PCCEI
Langue: English
Type de ressource: Journal article
Champs locaux: hal-03368935